⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Kaplan Fox Reminds ARS Pharmaceuticals Inc. (SPRY) Investors Seeking Recovery of the Lead Plaintiff Deadline on October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc. - October 5, 2026 Deadline
accessnewswire.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
SPRY
Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
The Gross Law Firm Reminds ARS Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - SPRY
globenewswire.com
SPRY
Levi & Korsinsky Urges ARS Pharmaceuticals (SPRY) Shareholders to Act Before Lead Plaintiff Deadline October 5, 2026
accessnewswire.com
SPRY
SPRY SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
accessnewswire.com
SPRY
Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Office is Investigating Claims on Your Behalf
globenewswire.com
SPRY
BE
ERAS
PODD
SPRY LAWSUIT ALERT: Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. Investors - Lead Plaintiff Deadline October 5, 2026
accessnewswire.com
SPRY
Pomerantz LLP Advises Shareholders of Class Action Filing Against ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY